Phase II trial of bisantrene in advanced colorectal carcinoma.
D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000627:therapeutic use / Q000633:toxicity; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012004:Rectal Neoplasms / Q000188:drug therapy*
D000873:Anthracenes; D000903:Antibiotics, Antineoplastic; C031404:bisantrene